Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer
M. Hofstad, A. Woods, K. Parra, Z. E. Sychev, A. Mazzagatti, L. Yu, C. Gilbreath, P. Ly, J. M. Drake, R. Kittler
This study shows that dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-deficient prostate cancer cells, with Compound B effectively achieving this in vitro and in vivo.
bioRxiv · Jul 10, 2024Cancer Biology